Clicky

Supernus Pharmaceuticals, Inc.(SUPN) News

Date Title
Oct 9 Supernus Pharmaceuticals Inc (SUPN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...
Sep 24 Busy Philipps Encourages Women to Take Charge of Their ADHD This Fall in Ongoing Collaboration with Supernus Pharmaceuticals and Qelbree
Sep 24 Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
Sep 19 Supernus Pharmaceuticals to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit
Aug 8 Supernus Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations
Aug 7 Supernus (SUPN) Reports Q2 Earnings: What Key Metrics Have to Say
Aug 6 Supernus Pharmaceuticals (SUPN) Misses Q2 Earnings Estimates
Aug 6 Supernus: Q2 Earnings Snapshot
Aug 6 Supernus Announces Second Quarter 2024 Financial Results
Jul 23 Supernus Pharmaceuticals to Announce Second Quarter 2024 FinancialĀ Results and Host Conference Call on August 6, 2024
May 30 Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
May 24 Do Options Traders Know Something About Supernus (SUPN) Stock We Don't?
May 10 Supernus Pharmaceuticals Reports Mixed Q1 2024 Results Amidst Strategic Shifts and Pipeline ...
May 10 Supernus Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.002 (vs US$0.31 in 1Q 2023)
May 9 Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures
May 9 Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q1 2024 Earnings Call Transcript
May 9 Supernus Pharmaceuticals Inc (SUPN) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
May 8 Compared to Estimates, Supernus (SUPN) Q1 Earnings: A Look at Key Metrics
May 8 Supernus Announces First Quarter 2024 Financial Results
May 7 M8 Pharmaceuticals, an Acino company, signs an exclusive licensing agreement with Supernus for QelbreeĀ® (Viloxazine XR) in Latin America